Results 51 to 60 of about 592,939 (351)

A survey of substance use for cognitive enhancement by university students in the Netherlands [PDF]

open access: yes, 2015
Background: Pharmacological cognitive enhancement, using chemicals to change cellular processes in the brain in order to enhance one's cognitive capacities, is an often discussed phenomenon.
Bundt, Carsten   +5 more
core   +3 more sources

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe the use of central stimulants and amantadine for fatigue in MS and evaluate a potential association with reduced work loss in people with MS. Methods We conducted a nationwide, matched, register‐based cohort study in Sweden (2006 to 2023) using national registers with prospective data collection.
Simon Englund   +3 more
wiley   +1 more source

Individual and county-level factors associated with use of multiple prescribers and multiple pharmacies to obtain opioid prescriptions in California. [PDF]

open access: yes, 2012
Use of multiple prescribers and pharmacies is a means by which some individuals misuse opioids. Community characteristics may be important determinants of the likelihood of this phenomenon independent of individual-level factors. This was a retrospective
Han, Huijun   +3 more
core   +2 more sources

Will Memantine Exacerbate Seizures in People With Epilepsy? A Prospective Cohort Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate whether add‐on memantine would exacerbate seizures in people with epilepsy. Methods This was a prospective cohort study. People with epilepsy diagnosed with cognitive impairment were consecutively invited. Those who agreed were followed up for at least 24 weeks.
Peiyu Wang   +7 more
wiley   +1 more source

Using prescribing and toxicology data to determine non-medical prescription drug overdose

open access: yesAddictive Behaviors Reports, 2020
Background: Overdose deaths have increased dramatically in the United States and are often attributed to prescription opioids. This study presents a framework for “overdose typologies”, including non-medical prescription drug use, to more accurately ...
Philip Huynh, Grant Victor, Brad Ray
doaj   +1 more source

An In-Depth Examination of Formularies and Other Features of Medicare Drug Plans [PDF]

open access: yes, 2006
Provides a detailed assessment of the formularies, drug costs, and utilization management tools offered by the fourteen nationwide organizations that account for most of the stand-alone prescription drug ...
Elizabeth Hargrave   +3 more
core  

Daratumumab Treatment for Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): A Case Report

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang   +8 more
wiley   +1 more source

Long working hours and use of psychotropic medicine: a follow-up study with register linkage

open access: yesScandinavian Journal of Work, Environment & Health, 2016
OBJECTIVE: This study aimed to investigate the possibility of a prospective association between long working hours and use of psychotropic medicine. METHODS: Survey data drawn from random samples of the general working population of Denmark in the time ...
Harald Hannerz, Karen Albertsen
doaj   +1 more source

Crystal structure of (E)-7-fluoro-2-((6-methoxypyridin-3-yl)methylene)-3,4-dihydronaphthalen-1(2H)-one, C17H14FNO2

open access: yesZeitschrift für Kristallographie - New Crystal Structures, 2021
C17H14FNO2, monoclinic, P21/c (no. 15), a = 7.3840(6) Å, b = 10.9208(8) Å, c = 16.7006(15) Å, β = 101.032(9)°, V = 1321.84(19) Å3, Z = 4, Rgt(F) = 0.0589, wRref(F2) = 0.1561, T = 100.00(18) K.
Su Xiang-Yi   +3 more
doaj   +1 more source

Retiree Health Benefits After Medicare Part D: A Snapshot of Prescription Drug Coverage [PDF]

open access: yes, 2008
Based on employer surveys, assesses how the introduction of the Medicare Part D prescription drug benefit affected employer-based retiree, drug, and other health ...
Heidi Whitmore   +2 more
core  

Home - About - Disclaimer - Privacy